Abstract
Sulfotransferase 1A1 (SULT1A1), also designated as phenol-preferring sulfotransferase, is involved in the bioactivation and detoxification of a variety of potential carcinogens, including iodothyronines, hydroxylated aromatic amines, and phenolic xenobiotics. A common arginine (R) to histidine (H) polymorphism at amino acid position 213 influences SULT1A1 activity and has been suggested as risk factor for a different types of cancers. To investigate the role of this polymorphism for breast cancer risk, SULT1A1 genotype was determined in 500 women with clinically verified breast cancer and 500 female age-matched healthy control subjects. Frequencies of heterozygous (controls: 42.5% patients: 50.2%) or homozygous (controls: 12.6%; patients: 9.4%) carriers of the 213H variant were not significantly different between groups. The SULT1A1 genotype was furthermore not associated with tumor size, histological grading, estrogen or progesterone receptor status and age at diagnosis. The SULT1A1 213H variant was associated with the presence of lymph node metastases (p = 0.002). We conclude that the SULT1A1 R213H polymorphism is not a general risk factor for breast cancer, but may be involved in lymph node metastazing in breast cancer patie...Continue Reading
References
Sep 1, 1992·Chemical Research in Toxicology·K el-Bayoumy
Apr 1, 1997·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·H Glatt
May 5, 1998·Chemico-biological Interactions·T P Dooley
Jul 21, 1999·Biochemical Pharmacology·R B RaftogianisR M Weinshilboum
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·K Nagata, Y Yamazoe
Jul 27, 2001·Pharmacogenetics·J A WilliamsD H Phillips
May 3, 2003·Breast Cancer Research and Treatment·Deliang TangFrederica Perera
Jul 8, 2003·International Journal of Cancer. Journal International Du Cancer·Peter KripplHellmut Samonigg
Oct 24, 2003·Breast Cancer Research and Treatment·Uwe LangsenlehnerHellmut Samonigg
Nov 6, 2003·Naunyn-Schmiedeberg's Archives of Pharmacology·Hansruedi Glatt, Walter Meinl
Nov 11, 2003·Cancer Letters·Peter KripplHellmut Samonigg
Jan 2, 2004·Breast Cancer Research and Treatment·Peter KripplHellmut Samonigg
Citations
Apr 1, 2006·Journal of Cancer Research and Clinical Oncology·Stefania BocciaGualtiero Ricciardi
Oct 24, 2006·Breast Cancer Research and Treatment·Armin GergerPeter Krippl
May 14, 2009·Breast Cancer Research and Treatment·Armin GergerUwe Langsenlehner
Dec 2, 2009·Breast Cancer Research and Treatment·Zhanwei WangWen-ming Chu
May 28, 2010·Breast Cancer Research and Treatment·Yiyi SunLin Sun
Oct 21, 2011·DNA and Cell Biology·Hui LeeJia-Yuan Li
Apr 28, 2006·Molekuliarnaia biologiia·E G ShatalovaO O Favorova
Jul 29, 2010·Journal of Experimental & Clinical Cancer Research : CR·Yiwei JiangJinsong Lu
Nov 11, 2005·Breast Cancer Research : BCR·Ekaterina G ShatalovaRebecca L Blanchard
Nov 12, 2014·Breast Cancer Research and Treatment·L OttiniD Palli
Mar 6, 2010·Journal of Cancer Research and Clinical Oncology·Gudrun KnechtelUwe Langsenlehner
Oct 30, 2009·Cancer Investigation·Volga S SyamalaRavindran Ankathil
Sep 17, 2014·PloS One·Juanjuan XiaoMinghua Wang
Oct 16, 2008·British Journal of Cancer·A KotnisR Mulherkar
May 20, 2009·Pharmacogenetics and Genomics·Michelle HildebrandtRuss B Altman
Sep 22, 2005·Breast Cancer Research and Treatment·Gong YangWei Zheng
Dec 26, 2006·Human Molecular Genetics·Scott J HebbringStephen N Thibodeau